Name | Number of supported studies | Average coverage | |
---|---|---|---|
endothelial cell | 19 studies | 28% ± 17% | |
endothelial cell of vascular tree | 10 studies | 46% ± 19% | |
oligodendrocyte | 9 studies | 25% ± 8% | |
endothelial cell of lymphatic vessel | 8 studies | 29% ± 8% | |
fibroblast | 7 studies | 25% ± 6% | |
astrocyte | 5 studies | 21% ± 5% | |
macrophage | 5 studies | 23% ± 7% | |
pericyte | 5 studies | 20% ± 5% | |
vein endothelial cell | 5 studies | 28% ± 13% | |
oligodendrocyte precursor cell | 5 studies | 31% ± 9% | |
type I pneumocyte | 4 studies | 24% ± 8% | |
endothelial cell of artery | 4 studies | 24% ± 9% | |
myofibroblast cell | 3 studies | 17% ± 1% | |
epithelial cell | 3 studies | 31% ± 8% | |
myeloid cell | 3 studies | 19% ± 1% | |
retinal cone cell | 3 studies | 27% ± 6% | |
basal cell | 3 studies | 42% ± 21% | |
capillary endothelial cell | 3 studies | 27% ± 13% | |
smooth muscle cell | 3 studies | 22% ± 2% | |
GABAergic neuron | 3 studies | 46% ± 7% | |
glutamatergic neuron | 3 studies | 49% ± 9% | |
interneuron | 3 studies | 35% ± 17% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
brain | 5 studies | 37% ± 10% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
brain | 100% | 5006.93 | 2642 / 2642 | 100% | 76.38 | 704 / 705 |
skin | 100% | 3303.50 | 1806 / 1809 | 99% | 84.33 | 465 / 472 |
kidney | 100% | 5419.85 | 89 / 89 | 96% | 53.81 | 864 / 901 |
esophagus | 99% | 3141.00 | 1428 / 1445 | 96% | 20.33 | 175 / 183 |
lung | 99% | 4284.63 | 574 / 578 | 95% | 21.48 | 1093 / 1155 |
intestine | 100% | 3750.77 | 966 / 966 | 94% | 17.22 | 493 / 527 |
stomach | 97% | 3121.50 | 349 / 359 | 95% | 18.07 | 272 / 286 |
breast | 100% | 6116.67 | 459 / 459 | 92% | 33.48 | 1032 / 1118 |
uterus | 99% | 2251.36 | 169 / 170 | 92% | 23.50 | 423 / 459 |
pancreas | 89% | 1418.78 | 293 / 328 | 98% | 22.06 | 174 / 178 |
thymus | 100% | 2866.34 | 650 / 653 | 87% | 26.55 | 529 / 605 |
bladder | 100% | 3048.24 | 21 / 21 | 87% | 19.15 | 438 / 504 |
liver | 100% | 6695.11 | 226 / 226 | 84% | 17.73 | 340 / 406 |
prostate | 98% | 2591.42 | 239 / 245 | 79% | 10.81 | 395 / 502 |
adrenal gland | 95% | 1756.87 | 246 / 258 | 80% | 15.54 | 185 / 230 |
ovary | 62% | 724.27 | 112 / 180 | 46% | 6.51 | 198 / 430 |
adipose | 100% | 4629.85 | 1204 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 99% | 3240.99 | 1325 / 1335 | 0% | 0 | 0 / 0 |
muscle | 99% | 2085.99 | 793 / 803 | 0% | 0 | 0 / 0 |
heart | 96% | 3562.54 | 824 / 861 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 96% | 18.88 | 43 / 45 |
spleen | 94% | 1137.93 | 227 / 241 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 76% | 11.67 | 61 / 80 |
lymph node | 0% | 0 | 0 / 0 | 69% | 7.67 | 20 / 29 |
peripheral blood | 14% | 147.77 | 128 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0048741 | Biological process | skeletal muscle fiber development |
GO_0033173 | Biological process | calcineurin-NFAT signaling cascade |
GO_0002931 | Biological process | response to ischemia |
GO_0006979 | Biological process | response to oxidative stress |
GO_0019722 | Biological process | calcium-mediated signaling |
GO_0070885 | Biological process | negative regulation of calcineurin-NFAT signaling cascade |
GO_0031987 | Biological process | locomotion involved in locomotory behavior |
GO_0007614 | Biological process | short-term memory |
GO_0005737 | Cellular component | cytoplasm |
GO_0005634 | Cellular component | nucleus |
GO_0005515 | Molecular function | protein binding |
GO_0008597 | Molecular function | calcium-dependent protein serine/threonine phosphatase regulator activity |
GO_0003676 | Molecular function | nucleic acid binding |
Gene name | RCAN1 |
Protein name | Calcipressin-1 (Adapt78) (Down syndrome critical region protein 1) (Myocyte-enriched calcineurin-interacting protein 1) (MCIP1) (Regulator of calcineurin 1) Calcipressin-1 (Regulator of calcineurin 1) |
Synonyms | ADAPT78 CSP1 DSCR1 DSC1 |
Description | FUNCTION: Inhibits calcineurin-dependent transcriptional responses by binding to the catalytic domain of calcineurin A . Could play a role during central nervous system development (By similarity). . |
Accessions | ENST00000399272.5 [P53805-3] ENST00000381135.7 ENST00000487990.5 [P53805-4] ENST00000482533.5 [P53805-4] E9PD55 ENST00000620920.4 [P53805-4] E9PDJ2 ENST00000492600.1 ENST00000381132.6 [P53805-2] V9GYW9 ENST00000481448.5 ENST00000443408.6 [P53805-4] P53805 ENST00000313806.9 [P53805-1] |